XML 33 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) Per Share
 9 Months Ended
Sep. 30, 2025
Income (Loss) Per Common Share  
Net Income (Loss) Per Share

Note 11 – Net Income (Loss) Per Share

 

The computations of basic and dilutive income (loss) per share of commons stock outstanding for the three and nine months ended September 30, 2025 and 2024 are as follows:

  

   Three Months Ended   Three Months Ended   Nine Months Ended   Nine Months Ended 
   September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
Net income (loss) available to common shareholders  $(2,962,000)  $1,195,000   $(12,738,000)  $(7,292,000)
Basic and diluted weighted average of common stock outstanding   2,568,508    9,095,504    2,337,272    7,341,204 
Income (loss) per common share   (1.15)   0.13    (5.45)   (0.99)

 

 

The computation of the fully diluted weighted average number of shares of common stock outstanding for the three and nine months ended September 30, 2025 and 2024 is as follows:

   

   Three Months Ended   Three Months Ended   Nine Months Ended   Nine Months Ended 
   September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
Basic weighted average common shares outstanding   2,568,508    9,095,504    2,337,272    7,341,204 
Effect of dilutive stock options and warrants   -    -    -    - 
Diluted weighted average of common shares outstanding   2,568,508    9,095,504    2,337,272    7,341,204 

 

Basic net income (loss) per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share reflects the potential dilution assuming shares of common stock underlying in-the-money options and warrants have been issued upon the exercise of the options and warrants and the proceeds thereof were used to purchase shares of the Company’s common stock at the average market price during the period using the treasury stock method.

 

For the three and nine months ended September 30, 2025, 484 of common stock underlying stock options, respectively, and 1,138,163 shares of common stock underlying warrants were excluded from the calculation of diluted net income (loss) per share as the result would have been anti-dilutive. For the three and nine months ended September 30, 2024, 543 shares of common stock underlying stock options and 4,511 shares of common stock underlying warrants were excluded from the calculation of diluted net income (loss) per share as the result would have been anti-dilutive.